Abstract
Although the differential for hypercalcemia in the surgical patient is broad, a stepwise approach to the diagnosis and management will ensure adequate management of this common electrolyte abnormality. Hyperparathyroidism and malignancy account for 90% of hypercalcemic patients. Treatment is largely etiology specific and may be altered based on the presence or absence of associated symptoms.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Lafferty FW. Differential diagnosis of hypercalcemia. J Bone Miner Res. 1991;6(S2):S51–9.
Ratcliffe WA, et al. Role of assays for parathyroid-hormone-related protein in investigation of hypercalcemia. Lancet. 1992;339(8786):164–7.
Koo WS, et al. Calcium-free hemodialysis for the management of hypercalcemia. Nephron. 1996;72(3):424.
Sandler LM, et al. Studies of the hypercalcemia of sarcoidosis: effect of steroids and exogenous vitamin D3 on the circulating concentrations of 1,25-dihydroxy vitamin D3. Q J Med. 1984;53(210):165–80.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Schoaps, R.S., Hazard, S.W. (2019). Management of Hypercalcemia. In: Docimo Jr., S., Pauli, E. (eds) Clinical Algorithms in General Surgery . Springer, Cham. https://doi.org/10.1007/978-3-319-98497-1_187
Download citation
DOI: https://doi.org/10.1007/978-3-319-98497-1_187
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-98496-4
Online ISBN: 978-3-319-98497-1
eBook Packages: MedicineMedicine (R0)